Valuation: Medpace Holdings, Inc.

Market Cap 16.24B 14.08B 13.2B 12.03B 22.64B 1,550B 23.01B 155B 60.67B 776B 60.98B 59.66B 2,589B P/E 2026 *
33.1x
P/E 2027 * 30.4x
Enterprise Value 15.44B 13.38B 12.55B 11.44B 21.53B 1,474B 21.87B 148B 57.67B 738B 57.97B 56.71B 2,461B EV / Sales 2026 *
5.41x
EV / Sales 2027 * 4.95x
Free-Float
79.96%
Yield 2026 *
-
Yield 2027 * -
1 day-2.52%
1 week-0.52%
Current month+0.84%
1 month+9.76%
3 months+37.33%
6 months+35.96%
Current year+3.61%
1 week 581.29
Extreme 581.29
608.18
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
8/11/26 A Sell

Chief Executive Officer

-17,610 0.0631%
8/7/26 A Fiscal year

Director

8,511 0.0305%
7/28/26 A Sell

Chief Operating Officer

-7,500 0.0263%
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%-0.52%+24.35%+118.05% 16.24B
-2.11%-1.68%+1.99%+13.84% 49.24B
-1.59%+2.12%+460.02%+573.56% 43.3B
-0.85%+7.95%+15.77%+80.09% 40.48B
-0.08%+3.91%+26.96%+9.86% 39.75B
0.00%+3.59%+20.51%+48.00% 32.67B
-3.61%-1.45% - - 16.23B
+1.00%+1.46%+4.89%+22.82% 14.04B
-1.09%+5.94%+81.46%+31.15% 13.43B
+0.19%+3.92%-5.00%-35.18% 12.92B
Average -1.06%+2.46%+70.11%+95.80% 27.83B
Weighted average by Cap. -1.11%+2.77%+91.16%+125.61%

Financials

2026 *2027 *
Net sales 2.85B 2.47B 2.32B 2.11B 3.98B 272B 4.04B 27.28B 10.65B 136B 10.71B 10.47B 454B 3.03B 2.62B 2.46B 2.24B 4.22B 289B 4.29B 28.96B 11.31B 145B 11.36B 11.12B 482B
Net income 503M 436M 408M 372M 701M 47.96B 712M 4.81B 1.88B 24.01B 1.89B 1.85B 80.09B 547M 474M 444M 405M 762M 52.17B 774M 5.23B 2.04B 26.11B 2.05B 2.01B 87.11B
Net Debt -802M -695M -652M -594M -1.12B -76.57B -1.14B -7.68B -3B -38.33B -3.01B -2.95B -128B -1.25B -1.09B -1.02B -928M -1.75B -120B -1.77B -11.98B -4.68B -59.82B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
13/08/26 $581.95 -2.52% 151,061
12/08/26 $596.98 -1.41% 310,387
11/08/26 $605.50 +0.51% 159,911
10/08/26 $602.43 +1.99% 233,638
07/08/26 $590.67 +0.97% 136,483
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
581.95USD
Average target price
581.83USD
Spread / Average Target
-0.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock